Multiple Sclerosis Clinical Trial

Clinical Trial Finder Multiple Sclerosis Trials

Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS)

See Locations Near You

Summary

The purpose of this study is to determine whether ozanimod is effective in the treatment of relapsing multiple sclerosis (RMS).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Multiple sclerosis as diagnosed by the revised 2010 McDonald criteria
EDSS score between 0 and 5.0 at baseline

Exclusion Criteria:

• Primary progressive multiple sclerosis

Study is for people with:

Multiple Sclerosis

Phase:

Phase 3

Estimated Enrollment:

1346

Study ID:

NCT02294058

Recruitment Status:

Completed

Sponsor:

Celgene

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 211 Locations for this study

See Locations Near You

Load More

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Phase:

Phase 3

Estimated Enrollment:

1346

Study ID:

NCT02294058

Recruitment Status:

Completed

Sponsor:


Celgene

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider